TPO-mimetics Before Splenectomy in Adult Primary Immune Thrombocytopenia Patients.

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829 ·Status: COMPLETED ·Phase: PHASE4

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

NCT06531018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

NCT04214951 ·Status: UNKNOWN

Indirect Comparison Between Eltrombopag & Romiplostim

NCT01236014 ·Status: COMPLETED

A Study of Switching Avatrombopag and Rh-TPO in ITP

NCT04913597 ·Status: UNKNOWN

Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic Purpura

NCT06137105 ·Status: NOT_YET_RECRUITING

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT01098487 ·Status: COMPLETED ·Phase: PHASE4

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

NCT02279173 ·Status: COMPLETED ·Phase: PHASE3

Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

NCT01143038 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP

NCT02338414 ·Status: UNKNOWN ·Phase: PHASE2

Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

NCT02402998 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

NCT01610180 ·Status: COMPLETED ·Phase: PHASE2

Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

NCT04917679 ·Status: COMPLETED ·Phase: PHASE2

Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP

NCT07189910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Efficacy and Safety of Romiplostim N01 Combined With Rituximab in Patients With Oral TPO-RA-Refractory Primary Immune Thrombocytopenia

NCT07206823 ·Status: RECRUITING ·Phase: NA

Immunomodulation With Romiplostim in Young Adults With ITP

NCT02760251 ·Status: COMPLETED ·Phase: PHASE4

Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)

NCT02868060 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

NCT05046327 ·Status: WITHDRAWN ·Phase: PHASE3

Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell

NCT01980030 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Eltrombopag in Patients With Delayed Post Transplant Thrombocytopenia.

NCT01791101 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults

NCT01013181 ·Status: COMPLETED

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT02868099 ·Status: COMPLETED ·Phase: PHASE3

Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP

NCT03119974 ·Status: COMPLETED ·Phase: PHASE4

Immune Thrombocytopenia Management in Adults

NCT05861297 ·Status: UNKNOWN ·Phase: PHASE4

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

NCT01129024 ·Status: TERMINATED ·Phase: PHASE2